Lung Cancer

Overview

Lung cancer is a malignant disease characterized by the uncontrolled growth of abnormal cells in the tissues of the lung, and it is among the leading causes of cancer-related death worldwide. It is broadly classified into non-small cell and small cell types, which differ in their biology, progression, and treatment. Because early-stage lung cancer often produces few symptoms, many cases are detected at an advanced stage, which makes early detection and screening important for improving outcomes. Treatment is tailored to the tumor's type and stage and may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, frequently used in combination. Research published in this journal addresses a range of issues related to lung cancer and oncology more broadly. Contributions review the potential roles of agents such as statins and heparin in lung cancer, examine metastatic patterns including adrenal involvement, and consider surgical approaches such as sub-lobar resection and the influence of immunotherapy on surgical practice. Other work explores cancer biomarker development and disease-modeling platforms, the biology of tumor cells, complementary and alternative approaches to cancer prevention, and supportive care issues such as cancer-related cachexia and nutrition. Recurring themes include early detection and screening, prevention, the molecular and cellular biology of tumors, evolving treatment strategies, and the management of advanced and metastatic disease.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 22 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
  2025 · Discover Oncology
• Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
  2025 · Discover Oncology
• Development of in vitro laboratory models of the tumor immune microenvironment to evaluate quality parameters and specific efficacy of the dendritic cell vaccine
  2023 · Siberian Journal of Oncology
• Development of in vitro laboratory models of the tumor immune microenvironment to evaluate quality parameters and specific efficacy of the dendritic cell vaccine
  2023 · Siberian journal of oncology
• Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer
  Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
• The Role of Immunosuppressive Factors in the Prognosis of Cellular Therapy Efficacy in Patients with Solid Tumors
  2022 · Effective Pharmacotherapy
• Ouabain Effects on Human Anaplastic Thyroid Carcinoma 8505C Cells
  2022 · Cancers
• Ouabain Effects on Human Anaplastic Thyroid Carcinoma 8505C Cells
  2022 · Cancers

A sample of recent works citing this journal's research on Lung Cancer, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics